Rosuvastatin Completed Phase 3 Trials for Obesity, Abdominal Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01068626Rosuvastatin in Visceral Adiposity